| DC Field | Value | Language |
|---|
| dc.contributor.author | Peresypkina, A. A. | - |
| dc.contributor.author | Gubareva, V. O. | - |
| dc.contributor.author | Levkova, E. A. | - |
| dc.contributor.author | Shabelnikova, A. S. | - |
| dc.date.accessioned | 2022-04-29T09:49:37Z | - |
| dc.date.available | 2022-04-29T09:49:37Z | - |
| dc.date.issued | 2016 | - |
| dc.identifier.citation | Correction of retinal angiopathy of hypertensive type by minoxidil, sildenafil in experiment / A. A. Peresypkina [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol. 2, № 4.- P. 34-44. - Doi: 10.18413/2500-235X-2016-2-4-34-44. - Refer.: p. 43-44. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/46531 | - |
| dc.description.abstract | For the study of retinoprotective properties of pharmacological agents a model of retinal angiopathy of hypertensive type was created against the background of N-nitro-L-arginine methyl ester (L-NAME) administration in a dose 12.5 mg/kg rat body weight for 28 days. Detection of preconditioning properties of pharmacological agents may be a new approach in the correction and prevention of retinal angiopathy, which is the initial part of hypertensive retinopathy | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | retinal angiopathy of hypertensive type | ru |
| dc.subject | pharmacological preconditioning | ru |
| dc.subject | minoxidil | ru |
| dc.subject | sildenafil | ru |
| dc.subject | hypertensive retinopathy | ru |
| dc.title | Correction of retinal angiopathy of hypertensive type by minoxidil, sildenafil in experiment | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 2, № 4
|
